AU7377196A - Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation - Google Patents

Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation

Info

Publication number
AU7377196A
AU7377196A AU73771/96A AU7377196A AU7377196A AU 7377196 A AU7377196 A AU 7377196A AU 73771/96 A AU73771/96 A AU 73771/96A AU 7377196 A AU7377196 A AU 7377196A AU 7377196 A AU7377196 A AU 7377196A
Authority
AU
Australia
Prior art keywords
inflammation
steroid
glucocorticoid
concomitant
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73771/96A
Other languages
English (en)
Inventor
Jim Cai
William J. Kovacs
Peter E Lipsky
Xe-Lien Tao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olsen Nancy J
Original Assignee
XE LIEN TAO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XE LIEN TAO filed Critical XE LIEN TAO
Publication of AU7377196A publication Critical patent/AU7377196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU73771/96A 1996-09-27 1996-09-27 Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation Abandoned AU7377196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/015550 WO1998013057A1 (fr) 1996-09-27 1996-09-27 Compositions de liaison aux recepteurs steroidiens et preparations associees limitant les effets steroidiens, pour traiter immunosuppressions et inflammations

Publications (1)

Publication Number Publication Date
AU7377196A true AU7377196A (en) 1998-04-17

Family

ID=22255873

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73771/96A Abandoned AU7377196A (en) 1996-09-27 1996-09-27 Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation

Country Status (7)

Country Link
EP (2) EP1007066B1 (fr)
AT (1) ATE309813T1 (fr)
AU (1) AU7377196A (fr)
CA (2) CA2268099C (fr)
DE (1) DE69635462T2 (fr)
ES (1) ES2252760T3 (fr)
WO (1) WO1998013057A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1185281A1 (fr) * 1999-06-02 2002-03-13 Oxford Natural Products PLC Combinaison de glucosamine avec des extraits d'herbes de tripterygium, ligustrum et erycibe
GB0001703D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Assay
FR2952072B1 (fr) * 2009-11-05 2013-09-27 Pf Medicament Procede de production de triptolide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US4241536A (en) * 1976-11-10 1980-12-30 Saint Firmin Annette R Embryogenesis in vitro, induction of qualitative and quantitative changes in metabolites produced by plants and products thereof
US4328309A (en) * 1980-07-02 1982-05-04 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method for producing tripdiolide, triptolide and celastrol
WO1991013627A1 (fr) * 1990-03-14 1991-09-19 The Board Of Regents, The University Of Texas System Extraits de tripterygium wilfordii hook f et composants de ces derniers utiles pour l'immunosuppression
CN1095278A (zh) * 1993-05-14 1994-11-23 安庆市余良卿制药厂 雷公藤贴膏
AU2646295A (en) * 1994-05-18 1995-12-05 Ligand Pharmaceuticals, Inc. Screening for cytokine modulators
WO1996008262A1 (fr) * 1994-09-15 1996-03-21 Pharmagenesis, Inc. Composition et procede d'immunotherapie

Also Published As

Publication number Publication date
EP1645281A1 (fr) 2006-04-12
ATE309813T1 (de) 2005-12-15
CA2268099C (fr) 2008-12-16
DE69635462T2 (de) 2006-08-17
DE69635462D1 (de) 2005-12-22
EP1007066A1 (fr) 2000-06-14
ES2252760T3 (es) 2006-05-16
EP1007066A4 (fr) 2002-10-23
CA2268099A1 (fr) 1998-04-02
WO1998013057A1 (fr) 1998-04-02
EP1007066B1 (fr) 2005-11-16
CA2658989A1 (fr) 1998-04-02

Similar Documents

Publication Publication Date Title
EP1092433A3 (fr) Compositions et méthodes pour traiter ou prevenir les maladies inflammatoires
HK1027802A1 (en) Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
MX9606546A (es) Compuestos inhibidores de la enzima conversiva de interleukina-1 beta.
BG110703A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION
UA66745C2 (en) INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
CA2281844A1 (fr) Nouveaux steroides anti-oestrogenes, compositions pharmaceutiques associees et leur mode d'utilisation
WO1997022619A3 (fr) INHIBITEURS DE L'ENZYME CONVERTISSANT L'INTERLEUKINE-1$g(b)
WO1999062510A3 (fr) Compositions renfermant des agents anti-microtubules pour le traitement ou la prevention de maladies inflammatoires
WO2002047706A3 (fr) Inhibition sélective de la cox-2 au moyen d'extraits végétaux
WO2002047708A3 (fr) Inhibition selective de cox-2 a partir d'extraits de plantes comestibles
WO1998024804A3 (fr) INHIBITEUR DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE 1$g(b)
WO1999058555A3 (fr) Promedicaments de propofol solubles dans l'eau
WO1998051662A3 (fr) Composes et methodes d'inhibition de l'expression de vcam-1
WO2004046345A3 (fr) Utilisation de fragments hmgb en tant qu'agents anti-inflammatoires
IL137509A0 (en) Glucocorticoid-selective anti-inflammatory agents
UA72909C2 (en) Cinnamide derivatives useful in the treatment of inflammatory and immune diseases, a composition containing such derivatives and a method for the preparation of cinnamide derivatives
AU1711197A (en) Method for treating sexual dysfunctions
EP1032556A4 (fr) Composes pharmaceutiquement actifs et procedes d'utilisation
WO2001094951A3 (fr) Inhibiteurs d'inflammation induite par la proteine c reactive
AU7377196A (en) Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation
MX9701776A (es) Uso de factores de crecimiento similares a insulina i y ii para la inhibicion de la respuesta inflamatoria.
WO2000012045A3 (fr) Procede de traitement de troubles neuro-degeneratifs
WO2000071140A3 (fr) Procedes et compositions de modulation de la reponse immunitaire et de traitement des maladies inflammatoires
WO1999014234A3 (fr) Stimulation ou inhibition de l'angiogenese et de la cardiovascularisation